Murray Stahl's VNDA Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 23,736 shares of Vanda Pharmaceuticals Inc. (VNDA) worth $164,016, representing 0.00% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Murray Stahl has maintained a strategic position in VNDA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 1,088 shares. Largest reduction occurred in Q4 2023, reducing 1,088 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's Vanda Pharmaceuticals (VNDA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vanda Pharmaceuticals (VNDA) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -1,088 | Reduce 4.38% | 23,736 | $6.91 |
| Q4 2025 | -1,088 | Reduce 4.20% | 24,824 | $8.82 |
| Q3 2025 | +1,088 | Add 4.38% | 25,912 | $4.99 |
| Q2 2025 | -1,088 | Reduce 4.20% | 24,824 | $4.72 |
| Q4 2024 | +1,088 | Add 4.38% | 25,912 | $4.79 |
| Q3 2024 | -1,088 | Reduce 4.20% | 24,824 | $4.69 |
| Q4 2023 | -1,088 | Reduce 4.03% | 25,912 | $4.22 |
| Q1 2023 | +27,000 | New Buy | 27,000 | $6.79 |
Murray Stahl's Vanda Pharmaceuticals Investment FAQs
Murray Stahl first purchased Vanda Pharmaceuticals Inc. (VNDA) in Q1 2023, acquiring 27,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held Vanda Pharmaceuticals Inc. (VNDA) for 13 quarters since Q1 2023.
Murray Stahl's largest addition to Vanda Pharmaceuticals Inc. (VNDA) was in Q1 2023, adding 27,000 shares worth $183,330.
According to the latest 13F filing for Q1 2026, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 23,736 shares of Vanda Pharmaceuticals Inc. (VNDA), valued at approximately $164,016.
As of the Q1 2026 filing, Vanda Pharmaceuticals Inc. (VNDA) represents approximately 0.00% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in Vanda Pharmaceuticals Inc. (VNDA) was 27,000 shares, as reported at the end of Q1 2023.